Targeting two proteins in the BCL-2 pathway was specific to the mitochondria @bcmhouston @BCMFromtheLabs @BCM_Surgery @BCMCancerCenter #mesothelioma
R. Taylor Ripley, M.D. Thoracic Surgeon
@RTaylorRipley
Thoracic Surgeon @VUMCHealth @VUMedicine; Vice Chair of Clinical Research; MiTOLab: Mitochondria in Thoracic Oncology; Ingram Professor at Vanderbilt-Ingram CC.
3.2K Following 2K Followers 574 Posts
Latest posts 5
The mitochondria with highly damaged by targeting two proteins in the mitochondria @bcmhouston @BCMFromtheLabs @BCM_Surgery @BCMCancerCenter #mesothelioma
Actively enrolling in NEMO for patients with surgically resectable pleural #mesothelioma @BCM_Surgery @bcmhouston @BCMCancerCenter
@BCMFromtheLabs 713-798–LUNG (6376) or lungsched@bcm.edu
@BCMFromtheLabs 713-798–LUNG (6376) or lungsched@bcm.edu
Congrats to Dr. Yuan Xu and our team @BCM_Surgery @bcmhouston @BCMFromtheLabs @BCM_Thoracic who showed that co-targeting the mitochondria can induce lethal dysfunction in pleural #mesothelioma. @curemeso
doi.org/10.1158/1535-7…
doi.org/10.1158/1535-7…
aacrjournals.org Co-Targeting BCL-xL with MCL-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma Abstract. Diffuse mesothelioma is a rare but highly aggressive and treatment-resistant neoplasm with low survival rates. Effective therapeutic strategies are limited, and resistance to treatment is a... Congrats, Dr Davis! Well deserved. Looking forward to seeing years of outstanding work.
Thanks for the warm welcome! @UMMC @UMmedschoolView quoted post on X
